Less Ads, More Data, More Tools Register for FREE

Pin to quick picksICG Enterprise Trust Regulatory News (ICGT)

Share Price Information for ICG Enterprise Trust (ICGT)

Share Price is delayed by 15 minutes
Get Live Data
1,396.00    -2.00 (-0.14%)
Bid:
1,396.00
Ask:
1,404.00
Spread: 8.00 (0.573%)
Market Cap: £849.54m
ICGT Live PriceLast checked at - London Stock Exchange

Intraday ICG Enterprise Trust Share Chart

Interim Management Statement

19 May 2010 10:19

RNS Number : 1832M
Graphite Enterprise Trust PLC
19 May 2010
 



GRAPHITE ENTERPRISE TRUST PLC

 

INTERIM MANAGEMENT STATEMENT

QUARTER ENDED 31 MARCH 2010

 

Graphite Enterprise Trust PLC ('Graphite Enterprise' or 'the Company') presents its Interim Management Statement for the quarter ended 31 March 2010. This is the Company's first Interim Management Statement for its current financial year, as required by the UK Listing Authority's Disclosure and Transparency Rule 4.3.

 

Investment objective

The objective of Graphite Enterprise is to provide shareholders with long term capital growth through investment in unquoted companies, mostly through specialist funds but also directly.

 

Unaudited net asset value

In the three months to 31 March 2010 the unaudited net asset value per share fell by 1.1p or 0.2% to 463.0p.

 

The value of the investment portfolio increased by £1.1 million in the period and after adjusting for expenses and other movements, the net asset value before the accrual for the dividend for the year to December 2009 rose by £0.8 million.

 

The cost of the dividend was £1.6 million and after accounting for this the net asset value for the quarter fell by £0.8 million.

 

Share price and discount

The share price increased by 4.9% to 320.0p in the period. This compares with an increase of 5.4% in the FTSE All-Share Index. The rise in the share price reflected the narrowing of the discount to the net asset value per share from 34.3% to 30.9%.

 

The investment portfolio

The investment portfolio has been valued using the latest available managers' reports. As March valuations covering only 13.2% of the portfolio had been received by the cut-off date of 6 May, the majority of the portfolio has been valued using managers' reports as at 31 December.

 

Based on these figures, the underlying value of the portfolio in local currencies fell by 0.2% in the quarter. As rises in the euro and the US dollar against sterling increased the sterling value of the portfolio by 0.7%, the portfolio rose by a net 0.5% in the period.

 

Cash flows

In the three months to 31 March 2010, cash balances fell by £6.9 million from £114.0 million to £107.1 million. A total £12.3 million was invested in the period and £5.6 million of proceeds were received from the investment portfolio.

  

Balance sheet and commitments

The summary balance sheet as at 31 March 2010 is set out below:

 

£m

% of total assets

Total portfolio

239.0

69.5%

Cash and cash equivalents

107.1

31.2%

Net debtors/creditors

(2.3)

(0.7%)

Total assets

343.8

100.0%

Net asset value per share

463.0p

 

Outstanding commitments fell by £15.9 million or by 6.5% to £227.3 million during the period. Drawdowns of commitments to funds accounted for £12.3 million of the fall and the release of a commitment for a further £9.1 million. The commitment release did not have any impact on the net asset value in the quarter. These reductions were partially offset by a new commitment of £3.0 million and by the impact of exchange rate movements.

 

The level of overcommitment, being the amount by which commitments exceed cash and near cash, fell by £7.3 million to £122.5 million. This was equivalent to 35.6% of total assets at 31 March 2010.

 

Recent events

The Directors are not aware of any events or transactions which have taken place between 31 March 2010 and the date of publication of this statement which have had a material effect on the financial position of the company.

 

Change of accounting reference date

The Company is required to report its interim results within 60 days of the half year and to provide shorter updates within approximately 50 days of the ends of the first and third quarters. As valuation reports from private equity fund managers covering these periods often arrive after these reporting deadlines, the net asset values released at the half year and at the first and third quarters are often based on relatively out of date information.

 

The Board has therefore decided to change the Company's year end from 31 December to 31 January. This change of accounting reference date and the resultant changes to the half year and quarterly reporting dates, should ensure that future reports are based on more up to date information.

 

The next annual report and accounts will cover the thirteen month period from 31 December 2009 to 31 January 2011. The Company will publish its results for the six months to 30 June 2010 in mid to late July and will also release a more detailed set of results covering the seven months to 31 July 2010 towards the end of September. The Company's second Interim Management Statement for the current financial year will cover the three month period to 31 October 2010 and will be released in early December.

 

This information has not been audited or reviewed by the Company's auditors.

 

Enquires:

Stephen Cavell

Tim Spence

0207 825 5300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSMMGMKLLRGGZG
Date   Source Headline
31st Oct 20138:07 amRNSDisposal of Alexander Mann Solutions
25th Oct 20133:52 pmRNSNewsletter
3rd Oct 20132:48 pmRNSAnnouncement regarding Listing Rule 9.6.14
25th Sep 20134:45 pmRNSDirector/PDMR Shareholding
25th Sep 20137:00 amRNSHalf Yearly Report to 31 July 2013
8th Aug 201310:10 amRNSDisposal of Willowbrook Healthcare
5th Jul 20136:20 pmRNSNewsletter
3rd Jul 20139:56 amRNSHolding(s) in Company
26th Jun 20139:46 amRNSDirector/PDMR Shareholding
19th Jun 20132:51 pmRNSDirectorate Change
14th Jun 20133:18 pmRNSResult of AGM
13th Jun 20131:30 pmRNSInterim Management Statement
29th May 20131:24 pmRNSDisposal of Dominion Gas
13th May 20134:14 pmRNSDirector/PDMR Shareholding
18th Apr 20131:00 pmRNSAnnual Financial Report
17th Apr 201311:17 amRNSAnnouncement regarding Listing Rule 9.6.14
5th Apr 201312:58 pmRNSDirector/PDMR Shareholding
28th Mar 20137:02 amRNSUnaudited results for the year ended January 2013
27th Mar 20134:20 pmRNSAppointment of non-executive director
27th Mar 20134:14 pmRNSHolding(s) in Company
19th Dec 20125:01 pmRNSAudit committee appointment
6th Dec 20127:00 amRNSInterim Management Statement
26th Oct 20123:22 pmRNSAnnouncement in accordance with LR 9.6.14
5th Oct 201211:01 amRNSDisposal of NES Group
28th Sep 20127:00 amRNSHalf Yearly Report to 31 July
10th Jul 20123:47 pmRNSAudit committee appointment
22nd Jun 201212:18 pmRNSDirector/PDMR Shareholding
18th Jun 20124:11 pmRNSDirector/PDMR Shareholding
18th Jun 20127:00 amRNSDirector/PDMR Shareholding
14th Jun 20127:00 amRNSAGM Statement
11th Jun 20122:12 pmRNSInterim Management Statement 30 April 2012
28th May 201211:53 amRNSAnnual Information Update
9th May 20124:58 pmRNSAnnual Financial Report 31 Jan 2012
5th Apr 20127:00 amRNSFinal Results for the year ended 31 January 2012
27th Mar 20121:22 pmRNSAnnouncement re LR 9.6.13
30th Jan 201211:15 amRNSDirector/PDMR Shareholding
8th Dec 20117:00 amRNSInterim Management Statement
21st Nov 20111:03 pmRNSHolding(s) in Company
7th Oct 201111:58 amRNSIncrease in bank facility to £60 million
26th Sep 20117:00 amRNSHalf Yearly Report
22nd Jul 201112:14 pmRNSNOTIFICATION IN ACCORDANCE WITH LR 9.6.14
18th Jul 201111:30 amRNSDirector/PDMR Shareholding
14th Jul 20113:11 pmRNSDirectorate Change
24th Jun 20112:32 pmRNSDirector/PDMR Shareholding
16th Jun 20111:35 pmRNSAGM Statement 2011
15th Jun 201111:14 amRNSInterim Management Statement
2nd Jun 20112:04 pmRNSDisposal of Kurt Geiger
18th May 20115:24 pmRNSAnnual Information Update
19th Apr 20119:55 amRNSDirectorate update
18th Apr 20114:39 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.